Jeon Y, Kim D, Kim M, Kim B, Pak K, Kim J
BMC Endocr Disord. 2025; 25(1):6.
PMID: 39773438
PMC: 11707903.
DOI: 10.1186/s12902-024-01800-4.
Wang X, Ye Y, Amdulla M, Ren C, Liu Y, Ni S
Heliyon. 2024; 10(23):e40574.
PMID: 39654735
PMC: 11626026.
DOI: 10.1016/j.heliyon.2024.e40574.
Jeon Y, Suh Y, Lim S
Cancers (Basel). 2024; 16(19).
PMID: 39409875
PMC: 11475063.
DOI: 10.3390/cancers16193253.
Kim M
Endocrinol Metab (Seoul). 2024; 39(4):576-578.
PMID: 39223872
PMC: 11375302.
DOI: 10.3803/EnM.2024.401.
Gubbi S, Al-Jundi M, Foerster P, Cardenas S, Butera G, Auh S
Thyroid. 2024; 34(6):674-686.
PMID: 38717947
PMC: 11295840.
DOI: 10.1089/thy.2023.0711.
A comparative analysis of treatment efficacy in intermediate-risk thyroid cancer.
Abiri A, Nguyen T, Goshtasbi K, Torabi S, Kuan E, Armstrong W
Eur Arch Otorhinolaryngol. 2023; 280(5):2525-2533.
PMID: 36651960
DOI: 10.1007/s00405-023-07832-1.
Tc-Methylene Diphosphonate Treatment is Safe and Efficacious for Osteoporosis in Postmenopausal Differentiated Thyroid Cancer Patients Undergoing TSH Suppression: A Three-Center Non-Randomized Clinical Study.
Xie J, Yuan X, Mao W, Cai H, Gao K, Lv Z
Cancer Manag Res. 2022; 14:995-1005.
PMID: 35283644
PMC: 8906701.
DOI: 10.2147/CMAR.S354471.
Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis.
Kostopoulos G, Doundoulakis I, Antza C, Bouras E, Nirantharakumar K, Tsiachris D
Endocr Relat Cancer. 2021; 28(5):325-335.
PMID: 33794503
PMC: 8111325.
DOI: 10.1530/ERC-20-0496.
Anaplastic thyroid cancer: How far can we go?.
Amaral M, Afonso R, Gaspar M, Reis C
EXCLI J. 2020; 19:800-812.
PMID: 32636733
PMC: 7332787.
DOI: 10.17179/excli2020-1302.
Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
Lee M, Kim M, Choi H, Cho S, Lee G, Park Y
Endocrinol Metab (Seoul). 2019; 34(2):150-157.
PMID: 31099202
PMC: 6599911.
DOI: 10.3803/EnM.2019.34.2.150.
Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy.
Ma Y, Zhang X, Wang Y
Oncol Lett. 2017; 14(6):7405-7409.
PMID: 29250166
PMC: 5727597.
DOI: 10.3892/ol.2017.7173.
The effect of long-term thyroid-stimulating hormone suppressive therapy on the gonadal steroid hormones of patients with thyroid carcinoma after surgery.
Liu X, Zhou Y, Liang N, Hong Y, Dionigi G, Sun H
Gland Surg. 2017; 6(5):443-452.
PMID: 29142833
PMC: 5676168.
DOI: 10.21037/gs.2017.09.05.
Histological and ultrastructural alterations of rat thyroid gland after short-term treatment with high doses of thyroid hormones.
Ali Rajab N, Ukropina M, cakic-Milosevic M
Saudi J Biol Sci. 2017; 24(6):1117-1125.
PMID: 28855802
PMC: 5562382.
DOI: 10.1016/j.sjbs.2015.05.006.
Cardiac Effects of Thyrotropin Oversuppression with Levothyroxine in Young Women with Differentiated Thyroid Cancer.
Hong K, Son J, Ryu O, Choi M, Hong J, Lee S
Int J Endocrinol. 2016; 2016:9846790.
PMID: 27418929
PMC: 4935911.
DOI: 10.1155/2016/9846790.
An overall and dose-response meta-analysis for thyrotropin and thyroid cancer risk by histological type.
Hu N, Li Z, Liu J, Zhang Z, Wang L
Oncotarget. 2016; 7(30):47750-47759.
PMID: 27351286
PMC: 5216976.
DOI: 10.18632/oncotarget.10282.
Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer.
Hannoush Z, Weiss R
Rambam Maimonides Med J. 2016; 7(1).
PMID: 26886951
PMC: 4737508.
DOI: 10.5041/RMMJ.10229.
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y
Thyroid. 2015; 26(1):1-133.
PMID: 26462967
PMC: 4739132.
DOI: 10.1089/thy.2015.0020.
Radioiodine Remnant Ablation: A Critical Review.
Bal C, Padhy A
World J Nucl Med. 2015; 14(3):144-55.
PMID: 26420983
PMC: 4564915.
DOI: 10.4103/1450-1147.163240.
A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito J, Ito Y, Miyauchi A, Tuttle R
Thyroid. 2015; 26(1):144-9.
PMID: 26414743
PMC: 4842944.
DOI: 10.1089/thy.2015.0178.
Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.
Wang L, Smith A, Palmer F, Tuttle R, Mahrous A, Nixon I
Thyroid. 2014; 25(3):300-7.
PMID: 25386760
PMC: 6916125.
DOI: 10.1089/thy.2014.0287.
